The role of densitometry in the diagnostics of osteoporosis in rheumatoid arthritis

Secondary osteoporosis (OP) is a serious complication in patients with rheumatoid arthritis (RA). From 28 to 77% of RA patients have ostcopcnic syndrome and osteoporosis. The most important risk factors for OP in RA include severe disease, the absence of remission in RA, prolonged inadequate therapy with glucocorticoids (GC), and early menopause. There is a direct dependence of the development of OP with a RA of more than 7-10 years. Despite the powerfol anti-inflammatory effect, HA accelerates the development of OP, fractures and patient disability, especially in the first 6 months, taking the drug.